Abstract

Administered post-traumatic stress disorder based on ICD-11. The organizational and legal management of post-traumatic stress disorder’s pharmacotherapy based on evidence-based medicine and evidence-based pharmacy was studied. The use of medications to reduce post-traumatic stress disorder’s symptoms is indicated. Analgesics, anxiolytics, antidepressants, anticonvulsants, and drugs from other clinical-pharmacological groups can be used for analgesia, mood improvement, anxiety reduction, and control of hypergaining. Areas of professional reintegration (support in job search, skills training, education, employment, and adaptation to civilian life) have been determined. Legal support in the system of legal relations "doctor-patient-pharmacist-lawyer" indicated in order to achieve a comprehensive and multidimensional approach to the medical and pharmaceutical care of patients with post-traumatic stress disorder. Clinical and pharmacological management in the pharmacotherapy of post-traumatic stress disorder was studied. The further pharmaceutical development of the composition of the new drug based on the known active pharmaceutical ingredients of an analgesic and an antipsychotic is substantiated. Mentioned about the organizational and legal management of social patient-oriented pharmacotherapy, recent case studies of post-traumatic stress disorder in conflict conditions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call